Apollo Therapeutics
Biopharmaceutical company advancing a pipeline of transformative therapeutic programs sourced from leading UK universities including Imperial College London, UCL, and University of Cambridge.
Location
Cambridge, United Kingdom
Founded
2016
Investors
1
Categories
biotech, drug-discovery, university-spinout, therapeutics
Notes
Apollo Therapeutics is a unique biopharmaceutical company that partners with three of the UK's leading academic institutions - Imperial College London, University College London (UCL), and University of Cambridge - to identify, develop, and advance breakthrough therapeutic programs.
The company's model combines world-class academic science with industry expertise and venture backing to translate early-stage research into clinical-stage drug candidates across multiple therapeutic areas.
Team
- Ri Sherrington, Ph.D. - Chief Executive Officer
- LinkedIn: linkedin.com/in/risherrington
- Leadership team with pharma and academic backgrounds
Additional Research Findings
- Partnerships with Imperial College London, UCL, and University of Cambridge
- Pipeline spans oncology, immunology, neuroscience, and other areas
- Backed by major pharmaceutical companies and venture investors
- Unique academic-industry translation model
- Multiple programs in clinical development
- Headquarters in Cambridge, UK
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| AlbionVC (Healthcare) | London, UK | biotech-focused | seedseries-a+1 | 17 |